Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-065943

Options or other derivatives

  • Chief Medical Officer acquired 125,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Patel Naimish Chief Medical Officer 2024-05-28 Grant or award · Stock Option (Right to Buy) +85,000 85,000 D
Patel Naimish Chief Medical Officer 2024-05-28 Grant or award · Restricted Stock Units +40,000 40,000 D
Loading xslF345X05/ownership.xml…